| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. | SVP, Chief Legal Officer | Common Stock | 588,378 | $817,845 | $1.39 | 02 Feb 2026 | Direct |
| Akebia Therapeutics, Inc. | SVP, Chief Legal Officer | Stock Option (Right to buy) | 270,000 | 30 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | 02 Feb 2026 | 3 | -$96,983 | 4 | SVP, Chief Legal Officer | 04 Feb 2026, 16:12 |
| AKBA | Akebia Therapeutics, Inc. | 30 Jan 2026 | 2 | $0 | 4 | SVP, Chief Legal Officer | 03 Feb 2026, 16:40 |
| AKBA | Akebia Therapeutics, Inc. | 26 Jan 2026 | 0 | $0 | 3 | SVP, Chief Legal Officer | 03 Feb 2026, 16:32 |